These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
230 related articles for article (PubMed ID: 20097879)
21. Ionizing radiation enhances the therapeutic potential of TRAIL in prostate cancer in vitro and in vivo: Intracellular mechanisms. Shankar S; Singh TR; Srivastava RK Prostate; 2004 Sep; 61(1):35-49. PubMed ID: 15287092 [TBL] [Abstract][Full Text] [Related]
22. IG20 (MADD splice variant-5), a proapoptotic protein, interacts with DR4/DR5 and enhances TRAIL-induced apoptosis by increasing recruitment of FADD and caspase-8 to the DISC. Ramaswamy M; Efimova EV; Martinez O; Mulherkar NU; Singh SP; Prabhakar BS Oncogene; 2004 Aug; 23(36):6083-94. PubMed ID: 15208670 [TBL] [Abstract][Full Text] [Related]
23. Mechanisms of resistance to TRAIL-induced apoptosis in cancer. Zhang L; Fang B Cancer Gene Ther; 2005 Mar; 12(3):228-37. PubMed ID: 15550937 [TBL] [Abstract][Full Text] [Related]
24. Molecular mechanisms of resveratrol (3,4,5-trihydroxy-trans-stilbene) and its interaction with TNF-related apoptosis inducing ligand (TRAIL) in androgen-insensitive prostate cancer cells. Shankar S; Siddiqui I; Srivastava RK Mol Cell Biochem; 2007 Oct; 304(1-2):273-85. PubMed ID: 17636462 [TBL] [Abstract][Full Text] [Related]
25. Effect of Bax deficiency on death receptor 5 and mitochondrial pathways during endoplasmic reticulum calcium pool depletion-induced apoptosis. He Q; Montalbano J; Corcoran C; Jin W; Huang Y; Sheikh MS Oncogene; 2003 May; 22(17):2674-9. PubMed ID: 12730681 [TBL] [Abstract][Full Text] [Related]
26. The flavonolignan silibinin potentiates TRAIL-induced apoptosis in human colon adenocarcinoma and in derived TRAIL-resistant metastatic cells. Kauntz H; Bousserouel S; Gossé F; Raul F Apoptosis; 2012 Aug; 17(8):797-809. PubMed ID: 22555452 [TBL] [Abstract][Full Text] [Related]
27. Tumor necrosis factor-related apoptosis-inducing ligand retains its apoptosis-inducing capacity on Bcl-2- or Bcl-xL-overexpressing chemotherapy-resistant tumor cells. Walczak H; Bouchon A; Stahl H; Krammer PH Cancer Res; 2000 Jun; 60(11):3051-7. PubMed ID: 10850456 [TBL] [Abstract][Full Text] [Related]
28. Cisplatin-mediated c-myc overexpression and cytochrome c (cyt c) release result in the up-regulation of the death receptors DR4 and DR5 and the activation of caspase 3 and caspase 9, likely responsible for the TRAIL-sensitizing effect of cisplatin. Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q Med Oncol; 2015 Apr; 32(4):133. PubMed ID: 25796504 [TBL] [Abstract][Full Text] [Related]
29. eNOS protects prostate cancer cells from TRAIL-induced apoptosis. Tong X; Li H Cancer Lett; 2004 Jul; 210(1):63-71. PubMed ID: 15172122 [TBL] [Abstract][Full Text] [Related]
30. Differential roles of RelA (p65) and c-Rel subunits of nuclear factor kappa B in tumor necrosis factor-related apoptosis-inducing ligand signaling. Chen X; Kandasamy K; Srivastava RK Cancer Res; 2003 Mar; 63(5):1059-66. PubMed ID: 12615723 [TBL] [Abstract][Full Text] [Related]
31. Theaflavins target Fas/caspase-8 and Akt/pBad pathways to induce apoptosis in p53-mutated human breast cancer cells. Lahiry L; Saha B; Chakraborty J; Adhikary A; Mohanty S; Hossain DM; Banerjee S; Das K; Sa G; Das T Carcinogenesis; 2010 Feb; 31(2):259-68. PubMed ID: 19969555 [TBL] [Abstract][Full Text] [Related]
33. [Overcoming acquired resistance to tumor necrosis factor-related apoptosis-inducing ligand by Bcl-XL small interfering RNA in human colon cancer]. Zhu HB; Huang XF; Hu JZ; Zhou W; Chen W; Chen LL; He C Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):245-9. PubMed ID: 18788624 [TBL] [Abstract][Full Text] [Related]
34. Epidermal growth factor protects epithelial-derived cells from tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis by inhibiting cytochrome c release. Gibson EM; Henson ES; Haney N; Villanueva J; Gibson SB Cancer Res; 2002 Jan; 62(2):488-96. PubMed ID: 11809700 [TBL] [Abstract][Full Text] [Related]
35. Interactive effects of histone deacetylase inhibitors and TRAIL on apoptosis in human leukemia cells: involvement of both death receptor and mitochondrial pathways. Shankar S; Singh TR; Fandy TE; Luetrakul T; Ross DD; Srivastava RK Int J Mol Med; 2005 Dec; 16(6):1125-38. PubMed ID: 16273296 [TBL] [Abstract][Full Text] [Related]
36. Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II. Ravi R; Bedi A Cancer Res; 2002 Aug; 62(15):4180-5. PubMed ID: 12154014 [TBL] [Abstract][Full Text] [Related]
37. Synergistic antiproliferative effect of arsenic trioxide combined with bortezomib in HL60 cell line and primary blasts from patients affected by myeloproliferative disorders. Canestraro M; Galimberti S; Savli H; Palumbo GA; Tibullo D; Nagy B; Guerrini F; Piaggi S; Cine N; Metelli MR; Petrini M Cancer Genet Cytogenet; 2010 Jun; 199(2):110-20. PubMed ID: 20471514 [TBL] [Abstract][Full Text] [Related]
38. Smac induces cytochrome c release and apoptosis independently from Bax/Bcl-x(L) in a strictly caspase-3-dependent manner in human carcinoma cells. Hasenjäger A; Gillissen B; Müller A; Normand G; Hemmati PG; Schuler M; Dörken B; Daniel PT Oncogene; 2004 Jun; 23(26):4523-35. PubMed ID: 15064710 [TBL] [Abstract][Full Text] [Related]